IP Library Granted Patent US 10,781,460
Granted Patent B2
US 10,781,460 · App. 15/749,598 · Granted Sep 22, 2020

Diphosphomevalonate decarboxylase variant, and method for producing olefin compound by using the same

Inventors: Ryoko Orishimo (Wako, JP); Tomokazu Shirai (Wako, JP); Kazuhiro Takahashi (Tokyo, JP); Misao Hiza (Hiratsuka, JP); Yusuke Tanabe (Hiratsuka, JP)
Assignees: RIKEN; ZEON CORPORATION; THE YOKOHAMA RUBBER CO., LTD.
C12P5/026C12N5/10C12N9/88C12N15/09C12N15/52C12P5/02C12Y401/01033
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,781,460
App. No.
15/749,598
Granted
Sep 22, 2020
Kind
B2
Abstract

A method which enables olefin compound production with a high productivity and an enzyme used in the method, a mutation involving amino acid substitution has been introduced into various sites of diphosphomevalonate decarboxylase (MVD), thus preparing a large number of MVD variants. Next, the result of evaluating the variants for the catalytic activity related to the production of olefin compounds such as isoprene has revealed that MVD whose threonine at position 209 is substituted with a different amino acid has the catalytic activity, and that MVD whose arginine at position 74 is further substituted with a different amino acid in addition to position 209 has the catalytic activity at higher levels.

Claims (11)

1. A method for producing an olefin compound, the method comprising the step of reacting ATP and a compound represented by the following formula (1) in the presence of a diphosphomevalonate decarboxylase, wherein the diphosphomevalonate decarboxylase is a protein consisting of the amino acid sequence of SEQ ID NO: 2 in which the threonine at position 209 is substituted with arginine, aspartic acid, glutamic acid, glycine, alanine, serine, or histidine, and in which 1 to 40 amino acid residues are substituted, deleted, added, and/or inserted other than at position 209,

wherein in the formula (1), R 1 and R 2 each independently represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 15 carbon atoms, an aryl group having 6 to 20 carbon atoms, or a halogen atom and in the case of R 1 , the alkyl group and the alkenyl group each independently optionally is substituted with carboxyl group.

2. The production method according to claim 1 , wherein the reaction step is performed by culturing a host cell comprising:

a DNA encoding the diphosphomevalonate decarboxylase, or

a vector comprising the DNA.

3. The production method according to claim 1 , wherein, in the diphosphomevalonate decarboxylase, the arginine at position 74 of the amino acid sequence shown in SEQ ID NO: 2 is mutated to a different amino acid.

4. The production method according to claim 3 , wherein, in the diphosphomevalonate decarboxylase,

the threonine at position 209 of the amino acid sequence shown in SEQ ID NO: 2 is substituted with arginine, aspartic acid, glutamic acid, glycine, or alanine, and

the arginine at position 74 of the amino acid sequence shown in SEQ ID NO: 2 is substituted with methionine, histidine, glutamine, or lysine.

5. The production method according to claim 1 , wherein the olefin compound is isoprene.

6. The production method according to claim 1 , wherein the olefin compound is butadiene.

Assignments (2)
CHANGE OF ADDRESS FOR ASSIGNEE Recorded Nov 18, 2023
From: THE YOKOHAMA RUBBER CO., LTD.
To: THE YOKOHAMA RUBBER CO., LTD.
Reel/Frame 065626/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2018
From: ORISHIMO, RYOKO; SHIRAI, TOMOKAZU; TAKAHASHI, KAZUHIRO; HIZA, MISAO; TANABE, YUSUKE
To: RIKEN; ZEON CORPORATION; THE YOKOHAMA RUBBER CO., LTD.
Reel/Frame 045709/0790 →